Results 21 to 30 of about 241,274 (262)

Somatostatin subtype-2 receptor-targeted metal-based anticancer complexes [PDF]

open access: yes, 2012
Conjugates of a dicarba analogue of octreotide, a potent somatostatin agonist whose receptors are overexpressed on tumor cells, with [PtCl 2(dap)] (dap = 1-(carboxylic acid)-1,2-diaminoethane) (3), [(η 6-bip)Os(4-CO 2-pico)Cl] (bip = biphenyl, pico ...
González, Carlos A.   +24 more
core   +1 more source

Towards safety of oral anti-cancer agents, the need to educate our pharmacists

open access: yesSaudi Pharmaceutical Journal, 2017
Introduction: The global prevalence of cancer is rising. Use of oral anticancer medications has expanded exponentially. Knowledge about these medications as well as safe handling guidelines has not kept abreast with the rapidity these medications are ...
Sanaa Saeed Mekdad, Adher Dhaya AlSayed
doaj   +1 more source

A radiologist’s guide to novel anticancer therapies in the era of precision medicine

open access: yesEuropean Journal of Radiology Open, 2022
Novel anticancer agents have replaced conventional chemotherapy as first line agents for many cancers, with continued new and expanding indications.
Ali Khader   +6 more
doaj   +1 more source

VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [PDF]

open access: yesAl-Azhar Journal of Pharmaceutical Sciences, 2023
Inhibitors of vascular endothelial growth factor receptor -2 (VEGFR-2) are crucial biological targets for the development of novel anticancer medications.
Helmy Sakr   +3 more
doaj   +1 more source

A Multitargeted Approach in the Discovery of an Organorhodium Anticancer Agent Based On Vorinostat as a Potent Histone Deacetylase Inhibitor. [PDF]

open access: yes, 2020
The combination of more than one bioactive moiety in a mulitargeted anticancer agent may result in synergistic activity of its components. Using this concept, bioorganometallic compounds were designed to feature a metal center, a 2-pyridinecarbothioamide
Reynisson
core   +1 more source

Acetylenic Terrestrial Anticancer Agents

open access: yesNatural Product Communications, 2006
Acetylenic metabolites belong to a class of molecules containing triple bond(s). They are found in plants, fungi, microorganisms, and marine invertebrates.
Valery M Dembitsky, Dmitri O Levitsky
doaj   +1 more source

Organometallic iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis [PDF]

open access: yes, 2013
Platinum complexes related to cisplatin, cis-[PtCl2(NH3)2], are successful anticancer drugs; however, other transition metal complexes offer potential for combating cisplatin resistance, decreasing side effects, and widening the spectrum of activity ...
Hands-Portman, Ian   +5 more
core   +1 more source

Metal complexes as DNA intercalators [PDF]

open access: yes, 2011
DNA has a strong affinity for many heterocyclic aromatic dyes, such as acridine and its derivatives. Lerman in 1961 first proposed intercalation as the source of this affinity, and this mode of DNA binding has since attracted considerable research ...
Peter J. Sadler   +3 more
core   +1 more source

Bacteriocins as potential anticancer agents

open access: yesFrontiers in Pharmacology, 2015
Cancer remains one of the leading causes of deaths worldwide, despite advances in its treatment and detection. The conventional chemotherapeutic agents used for the treatment of cancer have nonspecific toxicity towards normal body cells that cause ...
Sukhraj eKaur, Sumanpreet eKaur
doaj   +1 more source

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections

open access: yesPharmaceuticals, 2023
Poor responses to medical care and the failure of pharmacological treatment for many high-frequency diseases, such as cancer and viral infections, have been widely documented.
Assunta D’Amato   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy